Hint mode is switched on Switch off

Roivant Sciences, ordinary share
ROIV, BMG762791017

Add a stock to WL
Choose all Reset all
Roivant Sciences, сountry — Bermuda
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Roivant Sciences Ltd. operates as a healthcare company. The Company offers investigational drugs in development for therapeutic areas such as dermatology, immunology, and respiratory diseases, as well as provides healthcare technologies which help healthcare institutions share ...
Roivant Sciences Ltd. operates as a healthcare company. The Company offers investigational drugs in development for therapeutic areas such as dermatology, immunology, and respiratory diseases, as well as provides healthcare technologies which help healthcare institutions share and aggregate data. Roivant Sciences provides services worldwide.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Roivant Sciences Ltd.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ROIV
  • Placement
    09.11.2022
  • Lock up period
    180
  • Number of papers
    721,171,465
  • Volume of raised funds
    150 mln USD
  • Placement share
    4.16%
  • Final placement price
    5 USD
  • Price change since placement date
    480.8%
  • By capitalization
    3,605.86 mln USD

IFRS/US GAAP reports

2026
I q eng
2025
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

05/03/2026 Roivant Sciences Ltd. (NASDAQ:ROIV) Maintains "Buy" Rating Amid Positive Momentum
03/03/2026 Roivant Sciences: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Other Information, Financial Statements And Exhibits
18/09/2025 Roivant Sciences (NASDAQ:ROIV) Stock Update and Phase 3 VALOR Study Results
10/09/2025 Roivant Sciences: Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
03/09/2025 Roivant Sciences: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.